Clinical Trial

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational registry study is to characterize postoperative recovery outcomes in adult patients receiving standard-of-care perioperative light therapy using an FDA-cleared photobiomodulation device as part of routine clinical practice. The study aims to describe changes in patient-reported and clinician-assessed recovery measures following elective surgical procedures. The main questions this registry aims to answer are: 1. How do patient-reported recovery outcomes, including pain, satisfaction, and perceived improvement, change over the postoperative period? 2. How do clinician-assessed indicators of recovery, such as swelling and bruising, change over time following surgery? This study does not include a randomized comparison group. Outcomes will be described longitudinally within participants based on data collected during routine care. Participants will: 1. Receive perioperative light therapy as part of standard clinical care, per their treating clinician 2. Complete patient-reported outcome questionnaires at defined postoperative time points 3. Undergo standardized clinical photography and routine clinical assessments as part of usual follow-up
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-29.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-02-13
Trial Details
NCT Number NCT07311889
Lead Sponsor Elixir MD Inc
Conditions Postoperative Pain, Postoperative Edema, Postoperative Ecchymosis, Surgical Wound Healing, Postsurgical Recovery
Enrollment 300 participants
Start Date 2026-01-19
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-17